Both BTN1A1 and BTNL2 have been reported to exert immunomodulatory functions and foster immune evasion when expressed on cancer cells (68, 100, 101) and BTNL2 has been associated with immunological disorders such as sarcoidosis (102). This evidence concerns the gene BTNL2 and cancer.